Front. Microbiol. Frontiers in Microbiology Front. Microbiol. 1664-302X Frontiers Media S.A. 10.3389/fmicb.2022.1128469 Microbiology Correction Expression of concern: Microbiome-based hypothesis on Ivermectin's mechanism in COVID-19: Ivermectin feeds bifidobacteria to boost immunity Frontiers Editorial Office *

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Frontiers Editorial Office ✉ editorial.office@frontiersin.org

This article was submitted to Infectious Agents and Disease, a section of the journal Frontiers in Microbiology

 05 01 2023 2022 13 1128469 20 12 2022 20 12 2022 Copyright © 2023 Frontiers Editorial Office. 2023 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Expression of Concern on Microbiome-based hypothesis on Ivermectin's mechanism in COVID-19: Ivermectin feeds bifidobacteria to boost immunity by Hazan, S. (2022). Front. Microbiol. 13:952321. doi: 10.3389/fmicb.2022.952321

With this notice, Frontiers states its awareness of the serious concerns raised regarding this article, which are now under investigation. The situation will be updated as soon as the investigation is complete.